3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
 
MMTC15_Header  
MMTC M Header 
Cancer-Channel Icon 

Recently, the heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, and genomic-based therapies that are increasing the success of personalized medicine.

Circulating Tumor Cells


Predictive Preclinical Models in Oncology


Cancer Molecular Markers


Translational to Clinical R&D


Technology-Driven Oncology Clinical Development

 

You may also be interested in:

Symposia:

Gene Editing - New

Cancer Immunotherapy - New

 

 



Premier Sponsors:

Leica Biosystems 
 

 NanoString2   

 

Singulex 

 

Jackson Laboratory - small logo